BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Ashvattha Therapeutics Reports the Ability to Tune Nanomedicines to Image Neuroinflammation in Multiple Sclerosis Patients and Tumor Associated Macrophages in Cancer at SNMMI Annual Meeting

  June 23, 2025

   · 

  3 min read
• Press Releases

  RAPT Therapeutics Names Two Industry Veterans to its Board of Directors

  June 23, 2025

   · 

  6 min read
• Press Releases

  ORYZON Announces Submission of Phase III Protocol to FDA to Initiate PORTICO-2 Trial of Vafidemstat in Borderline Personality Disorder (BPD) Patients

  June 23, 2025

   · 

  9 min read
• Press Releases

  Data Demonstrating Sotagliflozin Reduces the Risk of Clinically Important Hypoglycemic Events in Adults with Type 1 Diabetes When Added to Insulin Presented at the 85th Scientific Sessions of the American Diabetes Association (ADA)

  June 23, 2025

   · 

  5 min read
• Press Releases

  Data from the Phase 2 Clinical Trial of CX11/VCT220 in China Presented at ADA 2025

  June 23, 2025

   · 

  4 min read
• Press Releases

  Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary

  June 23, 2025

   · 

  2 min read
• Press Releases

  Hoth Therapeutics to host KOL Event Spotlighting HT-001, Novel Therapy

  June 23, 2025

   · 

  4 min read
• Press Releases

  Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT

  June 23, 2025

   · 

  9 min read
• Press Releases

  AltruBio Presents New Preclinical Data at FOCIS 2025 Demonstrating ALTB-268’s Efficacy in T Cell-Mediated Inflammatory Models

  June 23, 2025

   · 

  4 min read
• Press Releases

  Denovo Biopharma LLC Enters into an Exclusive Out-License Agreement with Chuang Yi Global Asset Management Co., Ltd. for Biomarker-Guided DB104 (liafensine) in Patients with Treatment-Resistant Depression (TRD) in Taiwan

  June 23, 2025

   · 

  2 min read